Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences 2019-10-26 18:01
Happiness Biotech Group Limited Announces Pricing of US$11 Million Firm Commitment Initial Public Offering 2019-10-25 22:00
Chugai Renews License to EpiVax's ISPRI In Silico Toolkit for Immunogenicity Assessment 2019-10-23 04:10
TissueCypher® Further Validated to Accurately Risk Stratify Barrett's Esophagus Patients With Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences 2019-10-23 01:59
New Horizon Health and Prenetics Establish Strategic Partnership to Launch ColoClear, the Chinese rival to ColoGuard, in Hong Kong and Southeast Asia 2019-10-21 20:00
Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma 2019-10-21 08:00
China Biologic Special Committee Retains Financial Advisor and Legal Counsel 2019-10-17 20:00
GELITA & Geltor Sign Letter of Intent to Commercialize First Animal-Free Biodesigned Collagen for Dietary Supplements, a Market with Huge Growth Potential 2019-10-17 18:32
MetGen Earns Acclaim from Frost & Sullivan for its Unique, Customized Enzyme Technologies, METNIN™ and ENZINE® 2019-10-17 15:00
Sirtex Medical appoints Kevin R. Smith as Chief Executive Officer 2019-10-16 22:00
The 26th China Yangling Agricultural High-tech Achievements Expo will begin on October 22 2019-10-16 19:28
Curiox Biosystems Achieves Commercialisation and Fund Raising Success in North Asia with the Support of Cornerstone Investor, ZIG Ventures 2019-10-16 07:00
Celemics Expedites Target Enrichment NGS Data Insights by Partnering With BlueBee on a Global Genomics Data Solution 2019-10-15 19:00
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules 2019-10-11 08:02
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million 2019-10-09 20:58
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial 2019-10-09 17:56
Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer 2019-10-08 08:00
Cross-industrial technologies make a splash in Asia Agri-Tech Expo in Taipei 2019-10-05 10:06
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine 2019-10-03 06:30
AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations 2019-10-01 07:00
1 296 297 298 299 300 440